MedTrace Logo

HIV Patients Cohort

NCT02203006 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1613

Last updated 2026-05-06

No results posted yet for this study

Summary

The purpose of this study is to improve our knowledge concerning HIV infection, treated or not, in the current conditions of care to optimize it.

Conditions

  • Patients Affected by the HIV

Interventions

BIOLOGICAL

OVIHD

7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Jean-Marc Tréluyer, MD, PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-19
Primary Completion
2030-11-19
Completion
2030-11-19

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203006 on ClinicalTrials.gov